Efficacy and safety of bevacizumab combined with EGFR‐TKIs in advanced non‐small cell lung cancer: A meta‐analysis

BACKGROUND: The aim of this study was to estimate the efficacy and safety of bevacizumab combined with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) in advanced non‐small cell lung cancer (NSCLC) patients. METHODS: We searched randomized controlled trials (RCTs) on bevacizu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yifan, Wang, Liming, Li, Xu, Zhang, Shuai, Yu, Jiangyong, Nie, Xin, Liu, Wenbo, Wu, Xiaonan, Zhang, Ping, Li, Yi, Li, Ailing, Ai, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720617/
https://www.ncbi.nlm.nih.gov/pubmed/34859599
http://dx.doi.org/10.1111/1759-7714.14214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720617/
https://www.ncbi.nlm.nih.gov/pubmed/34859599
http://dx.doi.org/10.1111/1759-7714.14214

Ejemplares similares